SB-674042 manufacturers
- SB-674042
-
- $45.00
-
2026-07-14
- CAS:483313-22-0
- Purity: 99.82%
- Supply Ability: 10g
- SB-674042
-
-
2026-07-13
- CAS:483313-22-0
- Min. Order: 1KG
- Purity: 98%
- Supply Ability: 20Tons
|
| | SB-674042 Basic information |
| Product Name: | SB-674042 | | Synonyms: | [5-(2-Fluorophenyl)-2-methyl-4-thiazolyl][2(S)-2-[(5-phenyl-1,3,4-oxadiazol-2-yl)methyl-1-pyrrolidinyl]methanone;SB 674042; SB674042;SB-674042;(S)-1-[5-[2-Fluorophenyl]-2-methylthiazol-4-yl]-1-[2-[[5-phenyl-[1,3,4]oxadiazol-2-yl]methyl]pyrrolidin-1-yl]methanone;(2S)- 1-[[5-(2-Fluorophenyl)-2-methyl-4-thiazolyl]carbonyl]-2-[(5-phenyl-1,3,4-oxadiazol-2-yl)methyl]-pyrrolidine (9CI);[5-(2-FLUOROPHENYL)-2-METHYL-1,3-THIAZOL-4-YL]-[(2S)-2-[(5-PHENYL-1,3,4-OXADIAZOL-2-YL)METHYL]PYRROLIDIN-1-YL]METHANONE;SB-674042, CID10204153;Methanone, [5-(2-fluorophenyl)-2-methyl-4-thiazolyl][(2S)-2-[(5-phenyl-1,3,4-oxadiazol-2-yl)methyl]-1-pyrrolidinyl]- | | CAS: | 483313-22-0 | | MF: | C24H21FN4O2S | | MW: | 448.51 | | EINECS: | | | Product Categories: | | | Mol File: | 483313-22-0.mol |  |
| | SB-674042 Chemical Properties |
| Boiling point | 655.9±65.0 °C(Predicted) | | density | 1.326±0.06 g/cm3(Predicted) | | storage temp. | 2-8°C | | solubility | DMSO: soluble10mg/mL, clear | | form | powder | | pka | 0.74±0.10(Predicted) | | color | white to beige | | InChIKey | HYBZWVLPALMACV-KRWDZBQOSA-N | | SMILES | Fc1c(cccc1)c2[s]c(nc2C(=O)N3[C@@H](CCC3)Cc4nnc([o]4)c5ccccc5)C |
| Hazard Codes | Xn | | Risk Statements | 22 | | WGK Germany | 3 | | Storage Class | 11 - Combustible Solids | | Hazard Classifications | Acute Tox. 4 Oral |
| | SB-674042 Usage And Synthesis |
| Uses | SB 674042 is a novel nonpeptide antagonist to OX-1. | | Biochem/physiol Actions | SB-674042 is potent and selective OX1R antagonist. SB-674042 binds with high affinity to OX1R and mediates intracellular calcium flux in OX1R-expressing cells. | | in vivo | SB-674042 (0.3 nM/0.3 μL; icv; single dose) reduces contextual and cues fear freezing responses in Stay animals in Stress Alternatives Model (SMA) in mice[4].
| Animal Model: | Stress-induced mice model (male C57BL/6NHsd mice, 22-26 g)[4] | | Dosage: | 0.3 nM/0.3 μL | | Administration: | Intracerebroventricular injection; subjected mice to 4 days of social aggression (days 1-4) | | Result: | Resulted 39.4% Escape and 60.6% Stay phenotypes among mice. |
| | IC 50 | OX1 Receptor: 3.76 nM (IC50); OX2 Receptor: 531 nM (IC50); OX1 Receptor: 1.1 nM (Ki); OX2 Receptor: 129 nM (Ki) | | storage | Store at +4°C |
| | SB-674042 Preparation Products And Raw materials |
|